Rx A

No Response

Rx B

Rx A

Rx B


Enhanced Response

Accelerating Immuno-Oncology candidates to and through clinic

Drug Impact

Our proprietary technology ensures preservation of human TiME,

to ascertain immunomodulatory strategies

Our customizable assay system provides a flexible and comprehensive  approach to prioritization of combinatorial strategies

Our platform's integrated phenotypic outcome and multi-omic data are useful in understanding  the potential mechanisms of action that underlie a response of interest

A variety of comprehensive readouts allow for identification of biomarkers that could potentially differentiate likely response to drug candidates and optimize patient stratification for clinical trials

Combination therapy
Mechanism of action
Biomarker Discovery

We provide insights that help our clients gain confidence

  • LinkedIn

Farcast Biosciences


Salarpuria Symphony

Commercial Building Electronic City

Bengaluru.Karnataka 560100, India


40 Palafox Place, Suite 300


FL 32502, USA

© 2020 by Farcast. Created with